QT
Quanterix Corporation
QTRX · NASDAQ
$3.16 -0.32% (-$0.01)
1M +13.93%
Market Cap $150.3M
P/E Ratio -
Div. Yield -
ROE 43.59%
Bulios Fair Price
$2.92
7.6% downside
Current Price
$3.16
Undervalued Fair Value Overvalued
According to Bulios Fair Price, QTRX is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/S 0.98x
P/B 0.63x
P/E N/A
Growth
51 /100
Stable Rev. growth 9.53%
Book val. growth 6.16%
EPS growth N/A
Profitability
17 /100
Weak Gross margin 42.60%
Net margin 80.29%
FCF margin 48.25%
Quality
6 /100
Poor ROIC 46.86%
ROE 43.59%
Asset turnover 0.48x
Debt
100 /100
Low Debt/Equity 0.14x
Current ratio 3.40x
Int. coverage N/A
Stability
52 /100
Moderate Beta 1.04x
Rev. volatility 6.48%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about QTRX
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Everett V. Cunningham
Employees
450
Headquarters
Billerica
Upcoming events
09 NOV
Earnings
Upcoming earnings report